Boston Scientific has positive spinal cord stimulation data
Boston Scientific announced positive one-year results from a trial evaluating its spinal cord stimulation technology.
Stay updated with breaking news from Wavewriter Alpha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boston Scientific announced positive one-year results from a trial evaluating its spinal cord stimulation technology.
Boston Scientific Corporation (NYSE:BSX) Q3 2023 Earnings Call Transcript October 26, 2023 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.5, expectations were $0.48. Operator: Good day, and welcome to the Boston Scientific Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be […]
Operator: Good day, and welcome to the Boston Scientific Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
MARLBOROUGH, Mass., Oct. 26, 2023 /PRNewswire/ -- Boston Scientific Corporation generated net sales of $3.527 billion during the third quarter of 2023, growing 11.2 percent on a reported basis,...
With global staffing issues and the supply situation gradually improving, Boston Scientific's (BSX) international business is expected to have improved further in the third quarter.